Region Brief
United Kingdom
UK AI policy, research institutions, and safety initiatives.
Active in AI safety policy and hosts key labs and regulatory efforts.
Related Coverage
- KPMG Pulls Agentic AI Report After Organizations Dispute Fabricated Case Studies
On June 13, 2026, KPMG removed its report “Redefining excellence in the age of agentic AI” from its websites after multiple named organizations said claims about their AI usage were untrue or misleading. GPTZero and Financial Times reporting linked inaccuracies to AI hallucinations; UBS, the U.K. NHS, Swiss Federal Railways, and Transport for London were among those disputing the content. A KPMG spokesperson said the firm was investigating.
- Isomorphic Labs Raises $2.1 Billion in Series B to Scale AI Drug Design Engine
On May 12, 2026, Isomorphic Labs, the AI-first drug design company spun out of Google DeepMind, announced a $2.1 billion Series B funding round led by Thrive Capital with participation from Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund to expand its IsoDDE platform and advance its therapeutic pipeline.
- OpenAI Launches Deployment Company, Acquires Tomoro for Enterprise FDEs
On May 11, 2026, OpenAI launched the OpenAI Deployment Company—a majority-controlled venture with about $4 billion of outside capital from TPG and other PE/investors—and agreed to acquire London applied-AI firm Tomoro, bringing roughly 150 forward-deployed engineers to embed inside customer organizations and ship production AI systems.